Works matching AU Caux, Christophe


Results: 56
    1

    Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production.

    Published in:
    Journal of Clinical Medicine, 2019, v. 8, n. 11, p. 1859, doi. 10.3390/jcm8111859
    By:
    • Bossennec, Marion;
    • Rodriguez, Céline;
    • Hubert, Margaux;
    • Di-Roio, Anthony;
    • Machon, Christelle;
    • Guitton, Jérôme;
    • Battiston-Montagne, Priscilla;
    • Couturier, Mathilde;
    • Marotte, Hubert;
    • Caux, Christophe;
    • Coury, Fabienne;
    • Ménétrier-Caux, Christine
    Publication type:
    Article
    2
    3

    Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-58220-8
    By:
    • Sakref, Candice;
    • Saby, Alexis;
    • Rodriguez, Céline;
    • Ardin, Maude;
    • Moudombi, Lyvia;
    • Doffin, Anne-Claire;
    • Gobbini, Elisa;
    • Voissiere, Aurélien;
    • Besson, Laurie;
    • Laoubi, Léo;
    • Böttcher, Jan;
    • Depil, Stéphane;
    • Hubert, Margaux;
    • Bendriss-Vermare, Nathalie;
    • Caux, Christophe;
    • Valladeau-Guilemond, Jenny
    Publication type:
    Article
    4
    5

    HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1200, doi. 10.1002/ajh.26647
    By:
    • Alcazer, Vincent;
    • Bonaventura, Paola;
    • Tonon, Laurie;
    • Michel, Emilie;
    • Mutez, Virginie;
    • Fabres, Clémentine;
    • Chuvin, Nicolas;
    • Boulos, Rasha;
    • Estornes, Yann;
    • Maguer‐Satta, Véronique;
    • Geistlich, Kevin;
    • Viari, Alain;
    • Metzeler, Klaus H.;
    • Hiddemann, Wolfgang;
    • Batch, Aarif M. N.;
    • Herold, Tobias;
    • Caux, Christophe;
    • Depil, Stéphane
    Publication type:
    Article
    6
    7

    Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study.

    Published in:
    Breast Cancer: Targets & Therapy, 2023, v. 15, p. 311, doi. 10.2147/BCTT.S400055
    By:
    • Mery, Benoîte;
    • Ménétrier-Caux, Christine;
    • Montané, Laure;
    • Heudel, Pierre-Etienne;
    • Ray-Coquard, Isabelle;
    • Bachelot, Thomas;
    • Derbel, Olfa;
    • Augereau, Paule;
    • Treilleux, Isabelle;
    • Berthet, Justine;
    • Nkodia, Axelle;
    • Bardin-Dit-Courageot, Christine;
    • Attignon, Valery;
    • Ferrari, Anthony;
    • Garin, Gwenaele;
    • Perol, David;
    • Caux, Christophe;
    • Dubois, Bertrand;
    • Trédan, Olivier
    Publication type:
    Article
    8

    Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas.

    Published in:
    Targeted Oncology, 2013, v. 8, n. 4, p. 261, doi. 10.1007/s11523-012-0249-2
    By:
    • el Sayadi, Hiba;
    • Pissaloux, Daniel;
    • Alberti, Laurent;
    • Tabone-Eglinger, Severine;
    • Ranchere, Dominique;
    • Decouvelaere, Anne Valérie;
    • Tabone, Eric;
    • Ray-Coquard, Isabelle;
    • Caux, Christophe;
    • Fayette, Jérome;
    • Blay, Jean-Yves
    Publication type:
    Article
    9

    Targeting regulatory T cells.

    Published in:
    Targeted Oncology, 2012, v. 7, n. 1, p. 15, doi. 10.1007/s11523-012-0208-y
    By:
    • Ménétrier-Caux, Christine;
    • Curiel, Tyler;
    • Faget, Julien;
    • Manuel, Manuarii;
    • Caux, Christophe;
    • Zou, Weiping
    Publication type:
    Article
    10
    11
    12

    Type 1 conventional dendritic cells and interferons are required for spontaneous CD4<sup>+</sup> and CD8<sup>+</sup> T‐cell protective responses to breast cancer.

    Published in:
    Clinical & Translational Immunology, 2021, v. 10, n. 7, p. 1, doi. 10.1002/cti2.1305
    By:
    • Mattiuz, Raphaël;
    • Brousse, Carine;
    • Ambrosini, Marc;
    • Cancel, Jean‐Charles;
    • Bessou, Gilles;
    • Mussard, Julie;
    • Sanlaville, Amélien;
    • Caux, Christophe;
    • Bendriss‐Vermare, Nathalie;
    • Valladeau‐Guilemond, Jenny;
    • Dalod, Marc;
    • Crozat, Karine
    Publication type:
    Article
    13

    CD163<sup>+</sup> tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes.

    Published in:
    Clinical & Translational Immunology, 2020, v. 9, n. 2, p. 1, doi. 10.1002/cti2.1108
    By:
    • Ramos, Rodrigo Nalio;
    • Rodriguez, Céline;
    • Hubert, Margaux;
    • Ardin, Maude;
    • Treilleux, Isabelle;
    • Ries, Carola H;
    • Lavergne, Emilie;
    • Chabaud, Sylvie;
    • Colombe, Amélie;
    • Trédan, Olivier;
    • Guedes, Henrique Gomes;
    • Laginha, Fábio;
    • Richer, Wilfrid;
    • Piaggio, Eliane;
    • Barbuto, José Alexandre M;
    • Caux, Christophe;
    • Ménétrier‐Caux, Christine;
    • Bendriss‐Vermare, Nathalie
    Publication type:
    Article
    14

    Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients.

    Published in:
    OncoImmunology, 2024, v. 13, n. 1, p. 1, doi. 10.1080/2162402X.2024.2372118
    By:
    • Dalle, Stéphane;
    • Verronese, Estelle;
    • N'Kodia, Axelle;
    • Bardin, Christine;
    • Rodriguez, Céline;
    • Andrieu, Thibault;
    • Eberhardt, Anais;
    • Chemin, Gabriel;
    • Hasan, Uzma;
    • Le-Bouar, Myrtille;
    • Caramel, Julie;
    • Amini-Adle, Mona;
    • Bendriss-Vermare, Nathalie;
    • Dubois, Bertrand;
    • Caux, Christophe;
    • Ménétrier-Caux, Christine
    Publication type:
    Article
    15
    16

    MDR1 in immunity: friend or foe?

    Published in:
    OncoImmunology, 2018, v. 7, n. 12, p. 1, doi. 10.1080/2162402X.2018.1499388
    By:
    • Bossennec, Marion;
    • Di Roio, Anthony;
    • Caux, Christophe;
    • Ménétrier-Caux, Christine
    Publication type:
    Article
    17

    Immunological and classical subtypes of oral premalignant lesions.

    Published in:
    OncoImmunology, 2018, v. 7, n. 12, p. 1, doi. 10.1080/2162402X.2018.1496880
    By:
    • Foy, Jean-Philippe;
    • Bertolus, Chloé;
    • Ortiz-Cuaran, Sandra;
    • Albaret, Marie-Alexandra;
    • Williams, William N;
    • Lang, Wenhua;
    • Destandau, Solène;
    • Souza, Geneviève De;
    • Sohier, Emilie;
    • Kielbassa, Janice;
    • Thomas, Emilie;
    • Deneuve, Sophie;
    • Goudot, Patrick;
    • Puisieux, Alain;
    • Viari, Alain;
    • Mao, Li;
    • Caux, Christophe;
    • Lippman, SM;
    • Saintigny, P
    Publication type:
    Article
    18
    19
    20
    21
    22

    Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

    Published in:
    OncoImmunology, 2012, v. 1, n. 4, p. 432, doi. 10.4161/onci.19545
    By:
    • Manuel, Manuarii;
    • Trédan, Olivier;
    • Bachelot, Thomas;
    • Clapisson, Gilles;
    • Courtier, Anais;
    • Parmentier, Gilles;
    • Rabeony, Tioka;
    • Grives, Audrey;
    • Perez, Solène;
    • Mouret, Jean-François;
    • Perol, David;
    • Chabaud, Sylvie;
    • Ray-Coquard, Isabelle;
    • Labidi-Galy, Intidhar;
    • Heudel, Pierre;
    • Pierga, Jean-Yves;
    • Caux, Christophe;
    • Blay, Jean-Yves;
    • Pasqual, Nicolas;
    • Ménétrier-Caux, Christine
    Publication type:
    Article
    23
    24

    Design and methods of a national, multicenter, randomized and controlled trial to assess the efficacy of a physical activity program to improve health-related quality of life and reduce fatigue in women with metastatic breast cancer: ABLE02 trial.

    Published in:
    2020
    By:
    • Delrieu, Lidia;
    • Anota, Amélie;
    • Trédan, Olivier;
    • Freyssenet, Damien;
    • Maire, Aurélia;
    • Canada, Brice;
    • Fournier, Baptiste;
    • Febvey-Combes, Olivia;
    • Pilleul, Frank;
    • Bouhamama, Amine;
    • Caux, Christophe;
    • Joly, Florence;
    • Fervers, Béatrice;
    • Pialoux, Vincent;
    • Pérol, David;
    • Pérol, Olivia
    Publication type:
    journal article
    25
    26

    Breast carcinoma cells promote the differentiation of CD34.

    Published in:
    International Journal of Cancer, 2004, v. 110, n. 5, p. 710, doi. 10.1002/ijc.20146
    By:
    • Thomachot, Marie Cécile;
    • Bendriss-Vermare, Nathalie;
    • Massacrier, Catherine;
    • Biota, Cathy;
    • Treilleux, Isabelle;
    • Goddard, Sophie;
    • Caux, Christophe;
    • Bachelot, Thomas;
    • Blay, Jean Yves;
    • Menetrier-Caux, Christine
    Publication type:
    Article
    27
    28
    29
    30
    31

    Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells.

    Published in:
    International Journal of Cancer, 2015, v. 136, n. 5, p. 1085, doi. 10.1002/ijc.29087
    By:
    • Deauvieau, Florence;
    • Ollion, Vincent;
    • Doffin, Anne‐Claire;
    • Achard, Carole;
    • Fonteneau, Jean‐François;
    • Verronese, Estelle;
    • Durand, Isabelle;
    • Ghittoni, Raffaella;
    • Marvel, Jacqueline;
    • Dezutter‐Dambuyant, Colette;
    • Walzer, Thierry;
    • Vie, Henri;
    • Perrot, Ivan;
    • Goutagny, Nadège;
    • Caux, Christophe;
    • Valladeau‐Guilemond, Jenny
    Publication type:
    Article
    32

    Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells.

    Published in:
    International Journal of Cancer, 2013, v. 133, n. 3, p. 771, doi. 10.1002/ijc.28072
    By:
    • Sisirak, Vanja;
    • Vey, Nelly;
    • Goutagny, Nadège;
    • Renaudineau, Sarah;
    • Malfroy, Marine;
    • Thys, Sandra;
    • Treilleux, Isabelle;
    • Labidi‐Galy, Sana Intidhar;
    • Bachelot, Thomas;
    • Dezutter‐Dambuyant, Colette;
    • Ménétrier‐Caux, Christine;
    • Blay, Jean‐Yves;
    • Caux, Christophe;
    • Bendriss‐Vermare, Nathalie
    Publication type:
    Article
    33

    Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.

    Published in:
    Acta Neuropathologica, 2018, v. 135, n. 4, p. 569, doi. 10.1007/s00401-017-1802-y
    By:
    • Small, Mathilde;
    • Treilleux, Isabelle;
    • Couillault, Coline;
    • Pissaloux, Daniel;
    • Picard, Géraldine;
    • Paindavoine, Sandrine;
    • Attignon, Valery;
    • Wang, Qing;
    • Rogemond, Véronique;
    • Lay, Stéphanie;
    • Ray-Coquard, Isabelle;
    • Pfsterer, Jacobus;
    • Joly, Florence;
    • Du Bois, Andreas;
    • Psimaras, Dimitri;
    • Bendriss-Vermare, Nathalie;
    • Caux, Christophe;
    • Dubois, Bertrand;
    • Honnorat, Jérôme;
    • Desestret, Virginie
    Publication type:
    Article
    34
    35
    36
    37

    Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial.

    Published in:
    Cancers, 2022, v. 14, n. 5, p. 1189, doi. 10.3390/cancers14051189
    By:
    • Fumet, Jean-David;
    • Lardenois, Emilie;
    • Ray-Coquard, Isabelle;
    • Harter, Philipp;
    • Joly, Florence;
    • Canzler, Ulrich;
    • Truntzer, Caroline;
    • Tredan, Olivier;
    • Liebrich, Clemens;
    • Lortholary, Alain;
    • Pissaloux, Daniel;
    • Leary, Alexandra;
    • Pfisterer, Jacobus;
    • Eeckhoutte, Alexandre;
    • Hilpert, Felix;
    • Fabbro, Michel;
    • Caux, Christophe;
    • Alexandre, Jérôme;
    • Houlier, Aurélie;
    • Sehouli, Jalid
    Publication type:
    Article
    38
    39
    40
    41

    Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.

    Published in:
    BMC Cancer, 2011, v. 11, n. 1, p. 213, doi. 10.1186/1471-2407-11-213
    By:
    • Cassier, Philippe A.;
    • Treilleux, Isabelle;
    • Bachelot, Thomas;
    • Ray-Coquard, Isabelle;
    • Bendriss-Vermare, Nathalie;
    • Ménétrier-Caux, Christine;
    • Trédan, Olivier;
    • Goddard-Léon, Sophie;
    • Pin, Jean-Jacques;
    • Mignotte, Hervé;
    • Bathélémy-Dubois, Clarisse;
    • Caux, Christophe;
    • Lebecque, Serge;
    • Blay, Jean-Yves
    Publication type:
    Article
    42

    IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer.

    Published in:
    Science Immunology, 2020, v. 5, n. 46, p. 1, doi. 10.1126/sciimmunol.aav3942
    By:
    • Hubert, Margaux;
    • Gobbini, Elisa;
    • Couillault, Coline;
    • Manh, Thien-Phong Vu;
    • Doffin, Anne-Claire;
    • Berthet, Justine;
    • Rodriguez, Céline;
    • Ollion, Vincent;
    • Kielbassa, Janice;
    • Sajous, Christophe;
    • Treilleux, Isabelle;
    • Tredan, Olivier;
    • Dubois, Bertrand;
    • Dalod, Marc;
    • Bendriss-Vermare, Nathalie;
    • Caux, Christophe;
    • Valladeau-Guilemond, Jenny
    Publication type:
    Article
    43
    44

    Durable and controlled depletion of neutrophils in mice.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16596-9
    By:
    • Boivin, Gael;
    • Faget, Julien;
    • Ancey, Pierre-Benoit;
    • Gkasti, Aspasia;
    • Mussard, Julie;
    • Engblom, Camilla;
    • Pfirschke, Christina;
    • Contat, Caroline;
    • Pascual, Justine;
    • Vazquez, Jessica;
    • Bendriss-Vermare, Nathalie;
    • Caux, Christophe;
    • Vozenin, Marie-Catherine;
    • Pittet, Mikael J.;
    • Gunzer, Matthias;
    • Meylan, Etienne
    Publication type:
    Article
    45

    Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies.

    Published in:
    Breast Cancer Research & Treatment, 2020, v. 179, n. 2, p. 387, doi. 10.1007/s10549-019-05462-y
    By:
    • Carene, Dimitri;
    • Tran-Dien, Alicia;
    • Lemonnier, Jérôme;
    • Dalenc, Florence;
    • Levy, Christelle;
    • Pierga, Jean-Yves;
    • Jacot, William;
    • Canon, Jean-Luc;
    • Richon, Catherine;
    • Lacroix, Ludovic;
    • Caux, Christophe;
    • André, Fabrice;
    • Michiels, Stefan
    Publication type:
    Article
    46
    47
    48

    The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.

    Published in:
    Science Translational Medicine, 2024, v. 16, n. 731, p. 1, doi. 10.1126/scitranslmed.add1834
    By:
    • Voissière, Aurélien;
    • Gomez-Roca, Carlos;
    • Chabaud, Sylvie;
    • Rodriguez, Céline;
    • Nkodia, Axelle;
    • Berthet, Justine;
    • Montane, Laure;
    • Bidaux, Anne-Sophie;
    • Treilleux, Isabelle;
    • Eberst, Lauriane;
    • Terret, Catherine;
    • Korakis, Iphigénie;
    • Garin, Gwenaelle;
    • Pérol, David;
    • Delord, Jean-Pierre;
    • Caux, Christophe;
    • Dubois, Bertrand;
    • Ménétrier-Caux, Christine;
    • Bendriss-Vermare, Nathalie;
    • Cassier, Philippe A.
    Publication type:
    Article
    49
    50

    TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.

    Published in:
    Science Signaling, 2016, v. 9, n. 415, p. 1, doi. 10.1126/scisignal.aad1884
    By:
    • Viel, Sébastien;
    • Marçais, Antoine;
    • Guimaraes, Fernando Souza-Fonseca;
    • Loftus, Roisin;
    • Rabilloud, Jessica;
    • Grau, Morgan;
    • Degouve, Sophie;
    • Djebali, Sophia;
    • Sanlaville, Amélien;
    • Charrier, Emily;
    • Bienvenu, Jacques;
    • Marie, Julien C.;
    • Caux, Christophe;
    • Marvel, Jacqueline;
    • Town, Liam;
    • Huntington, Nicholas D.;
    • Bartholin, Laurent;
    • Finlay, David;
    • Smyth, Mark J.;
    • Walzer, Thierry
    Publication type:
    Article